🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Babak Tousi

Cleveland Clinic

ORCID: 0000-0002-4761-315X

Also affiliated with Lou Ruvo Brain Institute, Ferdowsi University of Mashhad

MedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology”.

Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology

Alzheimer s & Dementia(2024)10.1002/alz.13704
N/A
0.418DataRank · unranked
8 citations

James Bena, Babak Tousi, Kasia Gustaw Rothenberg, C. Dirk Keene, James B. Leverenz +1 more

Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus

Journal of Alzheimer s Disease(2025)10.1177/13872877251379076
N/A
0.241DataRank · unranked
4 citations

Megan Zelinsky, Paul J. Ford, James B. Leverenz, Jagan A. Pillai, Justin B. Miller +35 more

Combining genetics with real-world patient data enables ancestry-specific target identification and drug discovery in Alzheimer’s disease

Research Square(2025)10.21203/rs.3.rs-5716817/v1
N/A
0.208DataRank · unranked
3 citations

Yuan Hou, Pengyue Zhang, Yi‐Chen Li, Noah Lorincz‐Comi, Fan Fan +27 more

The Application of Zonisamide to Patients Suffering from Dementia with Lewy Bodies: Emerging Clinical Data

Drug Design Development and Therapy(2021)10.2147/dddt.s240865
N/A
0DataRank · unranked
6 citations

James Leverenz, Babak Tousi

Editorial: A Time of Transition of Alzheimer's Disease in the Advent of Anti-Amyloid Monoclonal Antibodies

Neurology and Therapy(2021)10.1007/s40120-021-00286-9
N/A
0DataRank · unranked
7 citations

Marwan N. Sabbagh, Babak Tousi